Vivus recalls

FDA enforcement reports naming Vivus, Inc. as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Jul 19, 2023

Severity

Jul 19, 2023PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only,…Drug · Vivus, Inc.Failed Stability SpecificationsClass III